Biomedicina y Biotecnología
Departamento
Brigham and Women's Hospital
Boston, Estados Unidos
Publicaciones en colaboración con investigadores/as de Brigham and Women's Hospital (1)
2022
- MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
Virchows Archiv, Vol. 480, Núm. 4, pp. 855-871
